ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 973

Serum IgG4 Concentrations Differ According to Race and Sex

Tyler Harkness1, Xiaoqing Fu 1, Yuqing Zhang 2, Hyon K. Choi 2, John Stone 3, Kimberly Blumenthal 1 and Zachary Wallace 1, 1Massachusetts General Hospital, Boston, 2Massachusetts General Hospital, Boston, MA, 3Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Immunoglobulin (IG), sex and race/ethnicity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: B Cell Biology & Targets In Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Elevated IgG4 concentrations are used to support a diagnosis of IgG4-related disease (IgG4-RD). IgG4 concentrations are reported to be higher in male IgG4-RD patients than in female patients and higher in Asian patients than in non-Asian patients. Similar observations have been made in studies of other immunoglobulin concentrations but were limited by relying on small cohorts with similar conditions/exposures or by excluding certain races.  There are scarce data on demographic differences in IgG4 concentrations. We assessed IgG4 concentration differences according to sex and race in a large cohort with demographic diversity.

Methods: The Partners Research Patient Data Registry (RPDR) was queried to identify patients who had ≥ one IgG subclass concentrations measured between January 1, 1989 and March 15, 2018 within the Partners HealthCare Network. Immunoglobulin (Ig) concentration test results, sex, date of birth, self-reported race, billing ZIP code (to estimate socioeconomic status [SES]), and diagnostic billing codes (to determine clinical indication for testing) were extracted. The distributions of IgG4 concentrations were compared across race and sex categories using t-tests and ANOVA tests, as appropriate. Multivariate-adjusted differences in IgG4 concentrations and the proportion of subjects with results above the reference range across race and sex subgroups were estimated using linear and logistic regression, respectively.

Results: Of the 12,851 subjects, the mean age was 54.7 (±18.3) years, 7,917 (62%) were female, 11,673 (91%) were White, 611 (5%) were Black, and 302 (2%) were Asian (Table 1).  Asian and Black subjects, compared to White subjects, had higher IgG4 concentrations (mean 140.4 and 53.6 vs. 41.6 mg/dL, p< 0.001) and more often had IgG4 concentrations above the ULN (24.8% and 12.0% vs. 7.0%; p< 0.001).  In age- and sex-adjusted analyses, Asian subjects had over a 4-fold higher odds (aOR 4.3, 95% CI 3.3-5.7) and Black subjects had a2-fold higher odds (aOR 1.9, 95% CI 1.4-2.4) of having an IgG4 above the ULN than White subjects. Males had higher IgG4 concentrations than females (mean 56.3 vs. 37.4 mg/dL, p< 0.001) and more often had IgG4 concentrations above the upper limit of normal (ULN) than females (10.5% vs 6.1%, p< 0.001; Table 2). In age- and race-adjusted analyses, females were 40% less likely than males to have an IgG4 above the ULN (aOR 0.6, 95% CI 0.5-0.6).  These differences persisted but were attenuated after adjustment for SES (Table 2). Our findings were similar when we stratified according to clinical indication. Similar observations were made when evaluating IgG, IgG1, IgG2, IgG3, IgA, and IgE concentrations (Table 3).

Conclusion: IgG4 concentrations differ according to race and sex and reflect similar differences observed in other Ig concentrations. These similarities suggest that a non-specific activation of Ig-producing B cells by environmental or genetic factors is responsible for these observations. These results have implications both for the interpretation of IgG4 concentration testing for the diagnosis of IgG4-RD and for the use of Ig concentrations in other clinical settings and research.

Cohort Characteristics

Unadjusted and Multivariate-Adjusted Differences in IgG4 Concentrations According to Sex and Race

Multivariate-Adjusted Differences in IgG, IgA, IgE, and IgM Concentrations According to Sex and Race


Disclosure: T. Harkness, None; X. Fu, None; Y. Zhang, None; H. Choi, AstraZeneca, 2, GSK, 5, Horizon, 5, Selecta, 5, Takeda, 5; J. Stone, Genentech, 2, 5, Roche, 2, 5, Xencor, 2, 5; K. Blumenthal, None; Z. Wallace, National Institute of Arthritis, Musculoskeletal, and Skin Diseases, 2, Rheumatology Research Foundation, 2.

To cite this abstract in AMA style:

Harkness T, Fu X, Zhang Y, Choi H, Stone J, Blumenthal K, Wallace Z. Serum IgG4 Concentrations Differ According to Race and Sex [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/serum-igg4-concentrations-differ-according-to-race-and-sex/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/serum-igg4-concentrations-differ-according-to-race-and-sex/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology